NCT04202965Phase 2Completed

PTG-300 in Subjects With Hereditary Hemochromatosis

Study sponsor: Protagonist Therapeutics, Inc. · PTGX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-10-06Actual
Enrollment · participants16Actual
Source updated2025-08-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.